Krebs Biochemicals and Industries Ltd Q3 FY2022-23 loss at Rs. 5.55 crore

Krebs Biochemicals and Industries Limited has reported Standalone financial results for the period ended December 31, 2022.

Financial Results (Q3 FY2023) - QoQ Comparison

The company has reported total income of Rs. 9.1136 crores during the period ended December 31, 2022 as compared to Rs. 21.2171 crores during the period ended September 30, 2022.

The company has posted net profit / (loss) of Rs. -5.5543 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. -4.0614 crores for the period ended September 30, 2022.

The company has reported EPS of Rs. -2.58 for the period ended December 31, 2022 as compared to Rs. -1.88 for the period ended September 30, 2022.

Financials	Q3 FY2023	Q2 FY2023	% Change
Total Income	₹9.1136 crs	₹21.2171 crs	-57.05%
Net Profit	₹-5.5543 crs	₹-4.0614 crs	36.76%
EPS	₹-2.58	₹-1.88	37.23%

Financial Results (Q3 FY2023) - YoY Comparison

The company has reported total income of Rs.9.1136 crores during the period ended December 31, 2022 as compared to Rs.22.0113 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.-5.5543 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.-12.9409 crores for the period ended December 31, 2021.

The company has reported EPS of Rs.-2.58 for the period ended December 31, 2022 as compared to Rs.-6 for the period ended December 31, 2021.

Financials	Q3 FY2023	Q3 FY2022	% Change
Total Income	₹9.1136 crs	₹22.0113 crs	-58.60%
Net Profit	₹-5.5543 crs	₹-12.9409 crs	57.08%
EPS	₹-2.58	₹-6	57.00%

Financial Results (9 Months Ended FY2023) - YoY Comparison

The company has reported total income of Rs.41.1008 crores during the 9 Months period ended December 31, 2022 as compared to Rs.40.9086 crores during the 9 Months period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.-17.7522 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.-33.2130 crores for the 9 Months period ended December 31, 2021.

The company has reported EPS of Rs.-8.23 for the 9 Months period ended December 31, 2022 as compared to Rs.-15.42 for the 9 Months period ended December 31, 2021.

Financials	9 Months Ended FY2023	9 Months Ended FY2022	% Change
Total Income	₹41.1008 crs	₹40.9086 crs	0.47%
Net Profit	₹-17.7522 crs	₹-33.2130 crs	46.55%
EPS	₹-8.23	₹-15.42	46.63%

Shares of Krebs Biochemicals and Industries Limited was last trading in BSE at Rs. 96.30 as compared to the previous close of Rs. 99.40. The total number of shares traded during the day was 1881 in over 136 trades.

The stock hit an intraday high of Rs. 101.10 and intraday low of 94.10. The net turnover during the day was Rs. 181387.00.

Source : Equity Bulls

Keywords

KrebsBiochemicalsandIndustries Q3FY23 9MFY23 ResultUpdate